Kelly Leanne M. 4
4 · Vallon Pharmaceuticals, Inc. · Filed Jun 4, 2021
Insider Transaction Report
Form 4
Kelly Leanne
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-06-02$4.00/sh+3,657$14,628→ 3,657 total - Purchase
Common Stock
2021-06-03$4.05/sh+1,085$4,394→ 4,742 total - Purchase
Common Stock
2021-06-04$4.08/sh+1,508$6,153→ 6,250 total